Medicare Enrolled
Dr. Kenneth Wasserman, MD
Internal Medicine · Englewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wasserman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wasserman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wasserman
Dr. Kenneth Wasserman is an internal medicine specialist in Englewood, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wasserman performed 1,948 Medicare services across 1,552 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wasserman received a total of $9,228 from 57 pharmaceutical and/or device companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wasserman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in NJ
$9,228 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,948
Medicare services
Top 23% in NJ for internal medicine
1,552
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
436 | $5 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
281 | $51 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $48 | $165 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
228 | $54 | $395 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
149 | $10 | $60 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
97 | $10 | $35 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
92 | $10 | $60 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
57 | $3 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $11 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $68 | $160 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
37 | $70 | $90 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
36 | $34 | $70 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
35 | $273 | $395 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
29 | $21 | $125 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $53 | $325 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
28 | $34 | $70 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
25 | $12 | $50 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $49 | $165 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
12 | $58 | $220 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
12 | $9 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,228
Total received (2018-2024)
Avg $1,318/year across 7 years
Top 8% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
669
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,101 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$127 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,339
2023
$1,429
2022
$1,364
2021
$1,524
2020
$1,249
2019
$970
2018
$1,352
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$265
PFIZER INC.
$168
Novo Nordisk Inc
$153
SANOFI-AVENTIS U.S. LLC
$88
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$66
AstraZeneca Pharmaceuticals LP
$64
GlaxoSmithKline, LLC.
$62
ABBVIE INC.
$50
Exact Sciences Corporation
$42
Janssen Biotech, Inc.
$39
Lundbeck LLC
$34
Medtronic, Inc.
$30
Xeris Pharmaceuticals, Inc.
$29
Astellas Pharma US Inc
$25
Aurinia Pharma U.S., Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$22
Otsuka America Pharmaceutical, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$18
Dexcom, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Currax Pharmaceuticals LLC
$16
ANI Pharmaceuticals, Inc.
$16
IBSA Pharma Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Lilly USA, LLC
$15
SOBI, INC
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,128
Amgen Inc.
$1,038
Lilly USA, LLC
$609
AstraZeneca Pharmaceuticals LP
$583
PFIZER INC.
$562
AbbVie Inc.
$543
GlaxoSmithKline, LLC.
$502
ABBVIE INC.
$316
Janssen Pharmaceuticals, Inc
$290
SANOFI-AVENTIS U.S. LLC
$283
Allergan, Inc.
$242
Teva Pharmaceuticals USA, Inc.
$227
Novartis Pharmaceuticals Corporation
$224
Amarin Pharma Inc.
$216
Boehringer Ingelheim Pharmaceuticals, Inc.
$210
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$205
Merck Sharp & Dohme Corporation
$194
Astellas Pharma US Inc
$188
Bayer Healthcare Pharmaceuticals Inc.
$129
E.R. Squibb & Sons, L.L.C.
$128
Biohaven Pharmaceuticals, Inc.
$103
Abbott Laboratories
$92
Lundbeck LLC
$84
Bayer HealthCare Pharmaceuticals Inc.
$76
Kowa Pharmaceuticals America, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$68
Eisai Inc.
$67
Biohaven Pharmaceutical Holding Company Ltd.
$54
Daiichi Sankyo Inc.
$50
Allergan Inc.
$49
Otsuka America Pharmaceutical, Inc.
$47
Xeris Pharmaceuticals, Inc.
$44
Exact Sciences Corporation
$42
Dexcom, Inc.
$41
Global Blood Therapeutics, Inc.
$40
Bardy Diagnostics, Inc.
$40
GE HealthCare
$39
Janssen Biotech, Inc.
$39
Medtronic, Inc.
$30
ARBOR PHARMACEUTICALS, INC.
$30
DEXCOM, INC.
$30
IDORSIA PHARMACEUTICALS US INC
$28
Aurinia Pharma U.S., Inc.
$24
Insulet Corporation
$21
IMPEL PHARMACEUTICALS INC.
$19
UCB, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Currax Pharmaceuticals LLC
$16
ANI Pharmaceuticals, Inc.
$16
Dynavax Technologies Corporation
$16
IBSA Pharma Inc.
$16
SANOFI PASTEUR INC.
$16
Sanofi Pasteur Inc.
$15
AbbVie, Inc.
$15
SOBI, INC
$14
JAZZ PHARMACEUTICALS INC.
$13
Almatica Pharma LLC
$13
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AJOVY · ANORO · AREXVY · Adempas · Aimovig · Austedo XR · BREO · BREZTRI · BRILINTA · BYSTOLIC · CHANTIX · CONTRAVE · CREON · Carnation Ambulatory Monitor · Cimzia · Cologuard Collection Kit · Corlanor · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELAPRASE · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FreeStyle Libre 2 · GRALISE · GVOKE HYPOPEN · Heplisav-B · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KINERET · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LUPKYNIS · LYRICA · Livalo · MAVYRET · MINIMED 780G · MOUNJARO · MYRBETRIQ · NORTHERA · NURTEC ODT · OXBRYTA · Omnipod · Otezla · Ozempic · PRALUENT · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SUNOSI · SYMBICORT · SYNJARDY · TAVNEOS · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRULICITY · TZIELD · Tirosint · Tresiba · Trudhesa · UBRELVY · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,942
Per 100K population
1146.1
County median income
$123,715
Nearest hospital
ENGLEWOOD HOSPITAL AND MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wasserman is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with low-engagement industry engagement in the top 8% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wasserman experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Wasserman performed 436 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wasserman receive payments from pharmaceutical companies?
Yes. Dr. Wasserman received a total of $9,228 from 57 companies across 669 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wasserman's costs compare to other internal medicine physicians in Englewood?
Dr. Wasserman's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wasserman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Englewood
Browse internal medicine physicians in Englewood ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology